Lotemax

DRUG6 trials

Sponsors

Medical University of South Carolina, Ophthalmic Consultants of Long Island, Innovative Medical, University of Michigan, Bausch & Lomb Incorporated

Conditions

Cataract ExtractionCataract SurgeryDry Eye DiseaseDry EyesKeratoconjunctivitis SiccaPseudophakia

Phase 2

Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)

CompletedNCT01817582

Bausch & Lomb IncorporatedKeratoconjunctivitis Sicca

Start: 2013-05-17End: 2014-01-10Updated: 2019-08-30

Phase 4

Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation

CompletedNCT00366691

Medical University of South CarolinaCataract Extraction

Start: 2006-02-28End: 2007-09-30Target: 40Updated: 2018-06-14

Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis

CompletedNCT00407043

Ophthalmic Consultants of Long IslandDry Eye Disease, Keratoconjunctivitis Sicca

Start: 2006-11-30End: 2007-09-30Updated: 2011-07-21

Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification

Innovative MedicalCataract Surgery, Pseudophakia

Start: 2010-09-30End: 2012-10-31Target: 100Updated: 2012-06-14

The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED

CompletedNCT02120079

Tufts Medical CenterDry Eye Disease

Start: 2014-02-28End: 2018-01-28Updated: 2024-06-26

Unknown Phase

Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%

CompletedNCT01695668

University of MichiganDry Eyes

Start: 2011-08-31End: 2015-02-28Updated: 2015-09-24

Related Papers

Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%.

2014-09-0146 citations